Retinoic acid receptor a mediates growth inhibition by retinoids in rat pancreatic carcinoma DSL-6A/C1 cells
1998

Retinoic Acid Receptor a and Its Role in Pancreatic Cancer Growth Inhibition

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): FH Brembeck, A Kaiser, K Detjen, H Hotz, T Foitzik, HJ Buhr, E-O Riecken, S Rosewicz

Primary Institution: Medizinische Klinik 1, FU Berlin

Hypothesis

The study aims to examine the effects of retinoids on cell growth in DSL-6A/C1 cells and to characterize the molecular mechanisms underlying these effects.

Conclusion

The RAR-a subtype predominantly mediates the antiproliferative effects of retinoids in DSL-6A/C1 cells.

Supporting Evidence

  • DSL-6A/C1 cells showed significant growth inhibition when treated with all-trans-retinoic acid.
  • Transactivation assays indicated that retinoic acid can stimulate gene expression linked to growth inhibition.
  • RAR-a specific agonists demonstrated comparable growth inhibitory effects to all-trans-retinoic acid.

Takeaway

This study shows that a substance called retinoic acid can help stop cancer cells from growing in a lab dish, and it works mainly through a specific receptor called RAR-a.

Methodology

The study used anchorage-dependent growth assays and transactivation assays to evaluate the effects of retinoids on DSL-6A/C1 cells.

Limitations

The study's findings may not directly translate to human pancreatic cancer due to differences in receptor expression patterns between rat and human cells.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication